The primary concern is the overall increase in testosterone levels, regardless of how it’s administered. The primary focus would then shift to treating the prostate cancer. In conclusion, the available evidence suggests that TRT does not cause prostate cancer. Several misconceptions surround the relationship between TRT and prostate cancer. The purpose of this screening is to identify any existing, undiagnosed prostate cancer. Before initiating TRT, men should undergo thorough prostate cancer screening. But they can actually reduce prostate size and lower the risk of needing surgery for BPH. Lowering DHT can help shrink the prostate over time and reduce BPH symptoms. Doctors can use medications and other tools to keep the prostate from growing too much or causing more problems. Testosterone replacement therapy (TRT) can help improve these symptoms. Many men with low testosterone also have an enlarged prostate, also called benign prostatic hyperplasia (BPH). Doctors may switch the type or lower the dose of TRT if a man develops worsening urinary symptoms. Learn more about the latest treatments for an enlarged prostate. Medical professionals may suggest one of several minimally invasive procedures that relieve BPH symptoms when medications do not work. Learn about some of the best medications for an enlarged prostate. If you have mild symptoms, you may not require any treatment. However, treatment options are available to help alleviate your symptoms. They’ll feel the edges and surface of your prostate, estimate the size of your prostate and detect any hard areas that could be cancer. Your healthcare provider will review your medical history, ask you questions and perform a physical examination. A urologist is a doctor who specializes in treating conditions that affect your urinary system. "The skin patches also resulted in fewer men experiencing hot flushes, however breast tissue swelling was more common. "This should give men greater choice over their treatment in the future, allowing them to live not just longer lives, but better lives." Experts said patients who are given injections of LHRH agonists (luteinising hormone-releasing hormone agonists) need multiple hospital or GP visits while oestradiol patches can be put on by patients at home. For example, early studies once suggested that high testosterone could lead to a higher risk of prostate cancer. Some worry that TRT could lead to faster prostate growth or raise the risk of problems like difficulty urinating or even prostate cancer. Regulators will need to approve oestradiol patches specifically for prostate cancer, not just menopause, before health systems such as the NHS can routinely offer them in this way. Women’s HRT patches can treat prostate cancer just as effectively as standard hormone injections – but with fewer of the worst side-effects – according to a large UK trial published in the New England Journal of Medicine. Treatment includes medications, surgery and minimally invasive procedures. It’s the most common prostate problem among males, affecting almost all of them as they age. BPH is the enlargement of the prostate gland, which can cause urinary problems. Therefore, rigorous screening before starting TRT and regular monitoring during treatment are essential to ensure patient safety and to mitigate any potential risks. As discussed, the key issue is the potential to accelerate the growth of existing cancer, not to induce the formation of new cancerous cells. While testosterone does not directly cause the formation of cancerous cells, it can act as a fuel for existing cancer cells. Low testosterone can lead to a variety of symptoms, including fatigue, decreased libido, erectile dysfunction, loss of muscle mass, and cognitive decline.
